RoopalBThakkarMD

Clinical Trials

• Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis Start of enrollment: 2006 Nov 01

  Completed

  Phase 3

• An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) Start of enrollment: 2007 Apr 01

  Completed

  Phase 3

• A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD) Start of enrollment: 2007 Sep 01

  Completed

• Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia Start of enrollment: 2008 Feb 01

  Completed

  Phase 3

• Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin Start of enrollment: 2008 Feb 01

  Completed

  Phase 3

• Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806 Start of enrollment: 2008 May 01

  Completed

  Phase 3

• A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting Start of enrollment: 2012 May 01

  Completed

  Phase 3

• Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease Start of enrollment: 2013 Dec 01

  Completed

  Phase 2

• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis Start of enrollment: 2014 Oct 13

  Completed

  Phase 3

• Join now to see all